Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MRPL23 Antisense RNA 1 (MRPL23-AS1) is a long non-coding RNA transcribed antisense to the MRPL23 gene. It does not produce a protein product and currently has no established role as a therapeutic target. Non-coding antisense RNAs can regulate the expression of adjacent or overlapping genes, typically through mechanisms such as transcriptional interference, RNA masking, or recruitment of chromatin-modifying complexes. However, there are no well-established biological or clinical functions or disease associations for MRPL23-AS1 as of current knowledge[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MRPL23 Antisense RNA 1 (MRPL23-AS1).